Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
The objective of this study is to assess the safety, tolerability and pharmacokinetic characteristics of BIII 890 after intravenous infusion in acute ischemic stroke patients.
Epistemonikos ID: 2bafe6c60e0dddf0f1d9b03e43b4c078cf7a921f
First added on: May 12, 2024